Table 5.
Guidance documents/products | Pharmacology |
Toxicology |
||||||
---|---|---|---|---|---|---|---|---|
Pharmacodynamics | Biodistribution/Pharmacokinetics | Mechanical property | Validation of clinical evaluation | Local toxicity | Systemic toxicity | Tumorigenicity | Genotoxicity | |
Guideline of the EU | ✔a | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
Guideline of the US | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | – |
Guideline of Japan | ✔ | ✔ | ✔ | – | ✔ | ✔ | ✔ | – |
Carticel® | ✔ | ✔ | – | – | ✔ | – | – | – |
ChondroCelect™ | ✔ | ✔ | – | – | ✔ | ✔ | ✔ | – |
JACC | ✔ | –b | – | – | ✔ | ✔ | ✔ | ✔ |
MACI® | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | – | ✔ |
EU, European Union; US, United States; JP, Japan.
✔: Described.
–: Not described.